SDGR icon

Schrodinger

Positive
Neutral
Negative
Sentiment 3-Months
Positive
Neutral 91.7%
Negative

Neutral
Business Wire
9 days ago
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
NEW YORK--(BUSINESS WIRE)--Schrödinger, Inc. (Nasdaq: SDGR) today reported that on May 18, 2026, the company granted (i) a non-statutory stock option to purchase 1,875 shares of the company's common stock to one newly hired employee and (ii) restricted stock units (RSUs) with respect to 18,766 shares of the company's common stock to seven newly hired employees. These grants were made pursuant to the company's 2021 Inducement Equity Incentive Plan, were approved by the compensation committee of.
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Neutral
24/7 Wall Street
13 days ago
7 Healthcare AI Stocks Under $50 With Huge Upside Potential
Healthcare AI stocks have been hammered in 2026, with several names down 30% to 65% year to date even as their underlying platforms keep maturing.
7 Healthcare AI Stocks Under $50 With Huge Upside Potential
Neutral
Seeking Alpha
17 days ago
Schrödinger, Inc. (SDGR) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Schrödinger, Inc. (SDGR) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Schrödinger, Inc. (SDGR) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Neutral
Seeking Alpha
25 days ago
Schrödinger, Inc. (SDGR) Q1 2026 Earnings Call Transcript
Schrödinger, Inc. (SDGR) Q1 2026 Earnings Call Transcript
Schrödinger, Inc. (SDGR) Q1 2026 Earnings Call Transcript
Negative
Zacks Investment Research
25 days ago
Schrodinger, Inc. (SDGR) Reports Q1 Loss, Misses Revenue Estimates
Schrodinger, Inc. (SDGR) came out with a quarterly loss of $0.81 per share versus the Zacks Consensus Estimate of a loss of $0.56. This compares to a loss of $0.82 per share a year ago.
Schrodinger, Inc. (SDGR) Reports Q1 Loss, Misses Revenue Estimates
Neutral
Business Wire
25 days ago
Schrödinger Reports First Quarter 2026 Financial Results
NEW YORK--(BUSINESS WIRE)--Schrödinger, Inc. announced financial results for the quarter ended March 31, 2026.
Schrödinger Reports First Quarter 2026 Financial Results
Neutral
Business Wire
27 days ago
Schrödinger to Participate in Upcoming Investor Conferences
NEW YORK--(BUSINESS WIRE)--Schrödinger, Inc. (Nasdaq: SDGR) today announced that management will participate in the following conferences in May: BofA Securities 2026 Healthcare Conference: Fireside chat on Wednesday, May 13, 2026, at 5:20 p.m. E.T. RBC 2026 Global Healthcare Conference: Fireside chat on Tuesday, May 19, 2026 at 2:05 p.m. E.T. The live discussions can be accessed in the “Investors” section of Schrödinger's website and will be archived for approximately 90 days following the eve.
Schrödinger to Participate in Upcoming Investor Conferences
Neutral
Business Wire
1 month ago
Schrödinger to Announce First Quarter 2026 Financial Results on May 5
NEW YORK--(BUSINESS WIRE)--Schrödinger, Inc. (Nasdaq: SDGR) will report its first quarter 2026 financial results on Tuesday, May 5, 2026, after the financial markets close. The company will host a conference call and webcast at 4:30 p.m. ET. The live webcast can be accessed in the “Investors” section of Schrödinger's website and will be archived for approximately 90 days following the event. About Schrödinger Schrödinger is transforming molecular discovery with its computational platform, which.
Schrödinger to Announce First Quarter 2026 Financial Results on May 5
Neutral
Business Wire
1 month ago
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
NEW YORK--(BUSINESS WIRE)--Schrödinger, Inc. (Nasdaq: SDGR) today reported that on April 16, 2026, the company granted restricted stock units (RSUs) with respect to 4,253 shares of the company's common stock to four newly hired employees. These grants were made pursuant to the company's 2021 Inducement Equity Incentive Plan, were approved by the compensation committee of the board of directors pursuant to a delegation by the company's board of directors, and were made as a material inducement t.
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Neutral
Seeking Alpha
2 months ago
Schrödinger, Inc. (SDGR) Presents at 2026 KeyBanc Capital Markets Healthcare Virtual Forum Transcript
Schrödinger, Inc. (SDGR) Presents at 2026 KeyBanc Capital Markets Healthcare Virtual Forum Transcript
Schrödinger, Inc. (SDGR) Presents at 2026 KeyBanc Capital Markets Healthcare Virtual Forum Transcript